Log in to your Inderes Free account to see all free content on this page.

Genovis

18.70 SEK

-1.16%

1,631 following

GENO

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Genovis

P/E

Median 2019-2025

EV/S

Median 2019-2021

EV/EBIT

Median 2019-2021

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)25.0031.5073.0045.9552.0024.7021.25
Shares63.165.065.565.565.5169.466.1
Market cap1,577.52,046.44,778.93,008.13,404.24,185.21,403.8
Enterprise value1,562.52,002.24,697.6----
EV/S25.832.850.5----
EV/EBITDA115.2233.6155.0----
EV/EBIT155.2637.7191.4----
P/E165.2317.5192.9241.855.349.459.0
P/B44.2923.4841.9223.9417.8418.365.17
P/S26.133.551.429.421.532.110.9
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio72.6 %81.7 %80.4 %83.5 %66.1 %69.6 %71.8 %
Gearing ratio------26.9 %
Login required

This content is only available for logged in users